Quality of Life and Hemoglobin Levels of Hemodialysis Patient at Siriraj Hospital
Authors: Tanita Thaweethamcharoen, M.Pharm, Rungpetch Sakulbumrungsil, Ph.D., Somkiat Vasuvattakul, M.D., Cherdchai Nopmaneejumruslers, M.D.
Number of views: 146
Objective: To evaluate the relationship of the quality of life (QOL), and hemoglobin (Hb) level of hemodialysis (HD) patients.
Methods: This study was a cross-sectional study. Face-to-face interviews using a Kidney Disease Quality of Life - Short
Form (KDQOL-SF™1.3) questionnaire (which consisted of SF-36 and kidney disease questionnaires) were conducted during
November-December 2009 with 152 patients receiving hemodialysis at Siriraj hospital, Bangkok, Thailand. QOL measures were
compared in stepwise Hb levels of ≤9, >9 to 10, >10 to 11, >11 to 12, and >12 g/dl. Scores of QOL and Hb level were
examined for the relationship and statistical significance by using ANOVA.
Results: The increasing Hb levels are statistically significant increases in kidney disease domain scores on the kidney disease
component of the questionnaire (p=0.042). About the SF36 component, the difference between 5 groups of Hb levels were
significant in the general health (p=0.023), role emotion (p=0.015), social functioning (p=0.008), and mental component summary
Conclusion: The difference of the Hb levels were statistically significant differences in the effects of kidney disease, general
health, role emotion, and social function scores, and mental component summary scores of the KDQOL-SF questionnaire.
However, a long-term assessment should be considered. These findings have implications for the care of hemodialysis patients
in terms of the initiation of the Hb target of erythropoietin (EPO) therapy.